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Purpose: Although various placebo acupuncture devices
have been developed and used in acupuncture research, there
is controversy concerning whether these devices really serve
as appropriate placebos for control groups. Now we are plan-
ning clinical research evaluating validity of various placebo
acupuncture device types. So now we are submit abstract of
the protocol.
Methods:Theproposed study is a single-center prospective
randomized crossover participant- and assessor-blinded trial
with two parallel arms. A total of 76 participants will be ran-
domly assigned toGroup 1 orGroup 2 in a 1:1 ratio. Participants
will have a total of three sessions in a day with a 30-minute
washout period between each session. The primary endpoint
is blinding test questionnaire 1. Secondary endpoints are the
Bang’s blinding index the Massachusetts General Hospital
Acupuncture Sensation Scale index, and physiological data
including heart rate, heart rate variability, and skin conduc-
tance response.
Results: We registered at CRIS(Clinical Research Informa-
tion Service, Korea). Registration Number is KCT0001347. Now
we are now recruiting participants.
Conclusion: This trial will evaluate the relevance of using
placebo acupuncture devices as controls using a validation
test procedure This study was supported by the Traditional
Korean Medicine R&D program funded by the Ministry of
Health andWelfare through theKoreanHealth IndustryDevel-
opment Institute (KHIDI) (No. HI13C0700)
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Purpose: Chronic heart failure (CHF) was characterized
by failure of enough blood supply from heart to meet the
body’s metabolic demands, and the prevalence of CHF con-
tinuously increases globally. The personalized diagnosis of
ChineseMedicine (CM)may help to stratify the CHF. CM classi-
ﬁes CHF into several different syndrome types, and integrating
Western and Chinese medicine to treat CHF has proved a val-
idated therapeutic approach. Metabolomics is regarded as a
potential platform to provide biomarkers for disease-subtypes
in recent years. In this research, we designed an explorative
study of 38 patients, combining NMR plasma metabolomics
with CM diagnosis in order to identify diagnostic biomarkers
for two CHF syndrome subtypes.
Methods:After processing theNMRdata, orthogonal partial
least square discriminant analysis (OPLS-DA) was performed.
Results: The plasma metabolic patterns of group 1 ‘Yin
deﬁciency VS non-Yin deﬁciency’ and 2 ‘Yang deﬁciency VS
non-Yang deﬁciency’ were clearly discriminated, respectively.
And potential biomarkers of CHF based on the two CM syn-
drome types indicated the alterativemodes ofmetabolites and
metabolic pathways in thedisease, e.g. the disturbance in fatty
acids, amino acids and glucose, etc.
Conclusion: This study proved that combining
metabolomics with CM diagnosis can reveal metabolic
signatures for CHF syndrome subtypes. The identiﬁed plasma
metabolites may be of special clinical relevance for sub-
types of CHF, which could lead to further understanding
of mechanisms involved and an improvement in personal-
ized interventions for CHF.This work was supported by The
National Science Foundation of China(no.81302914).
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